Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04505839
Title First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ST Pharm Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California Los Angeles California 90033 United States Details
University of Colorado Denver Denver Colorado 80045 United States Details
Northwestern University Evanston Illinois 60208 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field